Table 3.
Adverse effect | Grade |
|||
---|---|---|---|---|
≤ 2 | 3 | 4 | 5 | |
Hematologic adverse events | ||||
Anemia | 18 (51.4) | 2 (5.7) | 0 | 0 |
Neutropenia | 10 (28.6) | 2 (5.7) | 0 | 0 |
Thrombocytopenia | 10 (28.6) | 2 (5.7) | 0 | 0 |
Non-hematologic adverse events | ||||
Stomatitis | 6 (17.1) | 29 (82.9) | 0 | 0 |
Dysphagia | 31 (88.6) | 3 (8.6) | 0 | 0 |
Emesis | 8 (22.9) | 0 | 1 (2.3) | 0 |
Infection | 8 (22.9) | 4 (11.4) | 0 | 1 (2.3)a) |
Dermatitis | 20 (57.2) | 8 (22.9) | 0 | 0 |
Renal dysfunction | 5 (14.3) | 1 (2.3) | 0 | 0 |
Others | 8 (22.9) | 2 (5.7) | 1 (2.3) | 0 |
Persistent adverse events | ||||
Xerostomia | 25 (71.4) | 2 (5.7) | 0 | 0 |
Dysphagia | 20 (57.1) | 0 | 0 | 0 |
Neck fibrosis | 7 (20.0) | 0 | 0 | 0 |
Values are presented as number (%).
Expired due to pneumonia with septic shock.